APA (7th ed.) Citation

Jin, X., Zhang, S., Liang, J., Zhang, S., Qin, Y., Huang, Q., . . . Zhang, X. (2024). A PD‐L1‐targeting Regulator for Metabolic Reprogramming to Enhance Glutamine Inhibition‐Mediated Synergistic Antitumor Metabolic and Immune Therapy. Advanced materials (Weinheim), 36(6), e2309094-n/a. https://doi.org/10.1002/adma.202309094

Chicago Style (17th ed.) Citation

Jin, Xiao‐Kang, Shi‐Man Zhang, Jun‐Long Liang, Shun‐Kang Zhang, You‐Teng Qin, Qian‐Xiao Huang, Chuan‐Jun Liu, and Xian‐Zheng Zhang. "A PD‐L1‐targeting Regulator for Metabolic Reprogramming to Enhance Glutamine Inhibition‐Mediated Synergistic Antitumor Metabolic and Immune Therapy." Advanced Materials (Weinheim) 36, no. 6 (2024): e2309094-n/a. https://doi.org/10.1002/adma.202309094.

MLA (9th ed.) Citation

Jin, Xiao‐Kang, et al. "A PD‐L1‐targeting Regulator for Metabolic Reprogramming to Enhance Glutamine Inhibition‐Mediated Synergistic Antitumor Metabolic and Immune Therapy." Advanced Materials (Weinheim), vol. 36, no. 6, 2024, pp. e2309094-n/a, https://doi.org/10.1002/adma.202309094.